HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy

Open Access

Peer-reviewed

Research Article

Young-Ho Lee ,

* E-mail: lyh205@gmail.com (YL); dann@coh.org (DA)

Affiliation Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, California, United States of America
⨯
Xiyong Liu,

Affiliation Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, California, United States of America
⨯
Fuming Qiu,

Affiliation Department of Medical Oncology, Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China
⨯
Timothy R. O’Connor,

Affiliation Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America
⨯
Yun Yen,

Affiliation Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, California, United States of America
⨯
David K. Ann

* E-mail: lyh205@gmail.com (YL); dann@coh.org (DA)

Affiliation Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, California, United States of America
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Genetic causes of cancer
Is the Subject Area "Genetic causes of cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Immunohistochemistry techniques
Is the Subject Area "Immunohistochemistry techniques" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Data mining
Is the Subject Area "Data mining" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.